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Abstract 
In diabetic plasma, glycated albumin and glycated LDL coexist with augmented levels of peroxides, conditions frequently associated 
with the development of accelerated atherosclerosis. The direct interaction between irreversibly glycated albumin, LDL and oxidation 
have not been explored yet. We tried to elucidate whether irreversibly glycated albumin (AGE-Alb) induces changes in the chemistry and 
morphology of LDL particle, and if AGE&b has the ability to scavenge free radicals, as reported for native albumin. LDL isolated from 
normal (nLDL) or diabetic human subjects (dLDL) was incubated in vitro with AGE-Alb in conditions of autoxidation (37”C, 24-48 h in 
the absence of oxidation inhibitors) or of Cu*+ induced-oxidation. The results showed that, especially in the latter condition, AGE-Alb 
induced marked physico-chemical modifications of both nLDL and dLDL without significant changes in the level of peroxides. 
Incubation with AGE&b decreased the cholesteryl esters/unesterified cholesterol ratio of nLDL by 30% and of dLDL by N 50%. 
Concomitantly, in oxidative conditions a marked increase (- 3-fold) in the lysophosphatidylcholine/phosphatidylcholine ratio of dLDL 
was detected. Apolipoprotein B integrity as well as the morphology of the lipoprotein particles were drastically affected. To a lesser 
extent, these modifications occurred also in the presence of inhibitors of oxidation at 37”C, but not at 4°C. The above described effects 
were constantly more pronounced in the case of dLDL. These results indicated that in the absence of other plasma or vascular tissue 
components (e.g., endothelial cells, extracellular matrix) AGE&b by itself induces alterations in the chemistry and morphology of LDL, 
especially of glycated LDL, modifications that may account for the occurrence of accelerated atherogenesis in diabetes. 
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1. Introduction 
It is well documented that accelerated atherosclerosis is 
the main complication of diabetes. Non-enzymatic glyca- 
tion of proteins and increased concentration of plasma 
peroxides are common events in the pathogenesis of dia- 
betes mellitus and its chronic complications [l-3]. More- 
over, it was suggested that increased glycation may predis- 
pose proteins to oxidative damage [4], which can further 
impair the properties and functions of such altered pro- 
teins. Accumulation of advanced glycosylation end prod- 
ucts (AGES) is particularly critical for long-lived structural 
proteins, such as albumin. Irreversibly glycated albumin 
(AGE-Alb) has been demonstrated to undergo conforma- 
tional alterations, associated with decreased ligand binding 
capacity [5], the capability to generate superoxides and a 
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weak scavenging activity against peroxides [6]. Exposure 
to glucose also affects short-lived proteins, such as plasma 
low density lipoproteins (LDL) decreasing their interaction 
(in vitro) with the fibroblast LDL receptors [7]. Recent 
evidence indicated that the Maillard reaction represents a 
combination of both glycative and oxidative damage of 
proteins, yielding glycoxidation products [8]. The entire 
process might be especially precarious if these lipoproteins 
become sequestered in the vessel wall. In diabetic patients, 
the presence of non-enzymatically bound glucose on lipo- 
proteins such as LDL [9], may increase the likelihood of 
oxidative alterations, which could affect both the apopro- 
tein and the lipid moiety of the particle. Oxidatively 
modified LDL detected in atherosclerotic plaques in vivo 
[lo] was demonstrated to be highly atherogenic, cytotoxic 
to the cells of the vessel wall [ll], and stimulator of foam 
cell formation [121. 
In normal conditions, a number of antioxidants are 
present in the plasma, i.e., ascorbic acid, superoxide dis- 
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mutase, vitamin E, ceruloplasmin, transferrin, albumin, the 
latter being one of the most potent. Albumin is able to 
chelate traces of metal ions and to scavenge free radicals 
[13,14]. We have recently reported that, during in vitro 
peroxidation, albumin efficiently prevents the oxidative 
modifications of LDL and the formation of modified and 
reassembled lipoproteins [151. 
It was reported that in diabetes, the plasma level of free 
radical scavengers is decreased, while the thiobarbituric 
acid-reactive substances (TBARS) values are increased 
[ 161, and circulating (non-enzymatic reversibly and irre- 
versibly) glycated albumins occur [17]. In addition, the 
LDL is partly glycated and the Cu2+ total levels are higher 
in diabetics than in normal individuals reaching the highest 
level in diabetic patients with angiopathy and alterations in 
lipid metabolism [18]. However, no data are available so 
far on the possible direct effects of AGE-Alb on LDL 
(normal or glycated), or whether glycation is of pathophys- 
iological significance in the absence of other plasma and 
tissue components. 
Bearing on the above mentioned data, we asked the 
questions whether (a) in a cell-free system, devoid of any 
component of plasma or extracellular matrix, AGE-Alb has 
a direct effect on LDL exposed to mild (autoxidation) or 
strong (copper-induced) oxidation; (b) if LDL obtained 
from normal (nLDL) or diabetic patients (dLDL) with 
non-insulin dependent diabetes mellitus (NIDDM) respond 
differently when exposed to AGE-Alb, and (c> if AGE-Alb 
maintains the capacity (previously ascribed to native albu- 
min) to prevent the in vitro peroxidation of LDL. 
We report here that AGE&b induces physico-chemical 
alterations of LDL, which are particularly prominent for 
dLDL and specially pronounced in oxidative conditions. 
Like native albumin, but to a lesser extent, AGE-Alb is 
still able to prevent TBARS formation during LDL per- 
oxidation. 
2. Materials and methods 
2.1. Reagents 
Chemicals were obtained from the following sources: 
butylated hydroxytoluene (BHT), phenylmethylsulfonyl- 
fluoride (PMSF), disodium ethylenediamine tetraacetic acid 
(EDTA), sucrose, Tris (hydroxymethylaminomethane), p- 
mercaptoethanol, acrylamide, sodium dodecylsulfate 
(SDS), sodium phosphotungstate, 2-thiobarbituric acid, 
Folin-Ciocalteu phenol reagent and cholesterol enzymatic 
kit from Sigma (St. Louis, MO, USA), trichloroacetic acid 
and glucose from Fluka (Buchs, Switzerland). All organic 
solvents and chromatography plates Kieselgel 60 for thin- 
layer chromatography (TLC) were from Merck (Darms- 
tadt, Germany), bovine serum albumin (Cohn fraction V) 
was from Serva (Heidelberg, Germany). 
2.2. Probes 
Isolation of human serum LDL 
From fresh human sera of normal and type I diabetic 
subjects, LDL was isolated by density gradient ultracen- 
trifugation (within a density cut-off of 1.019 to 1.063 
g/ml) according to Redgrave et al. 1191. Both nLDL and 
dLDL were dialyzed against 10 mM Tris-buffered saline 
(pH 7.4) for 24 h at 4°C in the presence of 0.01% EDTA 
and 0.22 mM BHT. The two inhibitors were omitted from 
the buffer solution when LDL probes were subjected to 
oxidation. The stable but reversible Amadori products 
present in preparations of nLDL and dLDL were deter- 
mined by the thiobarbituric acid (TBA) method using as 
standard hydroxymethyl furfural (HMF) in concentrations 
ranging from 1.0. lo-’ M to 1.0. 1O-5 M [20]. 
Preparation of AGE-albumin 
To obtain advanced glycosylation endproducts (AGES), 
nonenzymatic glycosylation of albumin @lb) was con- 
ducted as indicated in [21,22]. Briefly, albumin (4%) was 
dissolved in 0.15 M phosphate-buffered saline (PBS) pH 
7.4 supplemented with 150 mM glucose in the presence of 
1.5 mM PMSF, penicillin (100 units/ml) and gentamycin 
(40 pg/ml). After passing through a 0.22 pm Millipore 
filter, the Alb solution was kept in a dry heat-sterilized 
tube at 37°C for 60 days. In some experiments, the AGE- 
Alb preparation was passed through a GlycoGel B column 
to remove reversibly glycated Alb. AGE-Alb was charac- 
terised by spectrofluorimetry [23] and by SDS-PAGE for 
protein purity. For control, Alb was incubated in the same 
conditions except that glucose was omitted. 
2.3. Incubation of normal and diabetic LDL with AGE-Alb 
The experimental protocols carried out consisted in 
incubating either nLDL or dLDL, in the presence or 
absence of AGE-Alb or of native Alb (as control), in one 
of the following conditions: (a) autoxidation, keeping the 
samples at 24-48 h at 37°C [24], (b) copper-induced 
oxidation, using 1pM copper sulfate in the same condi- 
tions as in (a) [25] and (c> autoxidation in the presence of 1 
mM EDTA and 0.22 mM BHT at 4°C or 37°C. For all 
experiments, 0.1 mg protein LDL/ml was incubated with 
different albumins in concentrations ranging from 0.01-1.0 
mg/ml in 10 mM Tris-buffered saline (pH 7.4). Oxidation 
was arrested by adding 1 mM EDTA and 0.22 mM BHT to 
each sample, and placing the tubes at 4°C. To ascertain the 
effect of the oxidative conditions, in separate experiments 
the probes were incubated in the presence or absence of 
AGE-Alb, at 4°C or at 37°C in the presence of 1 mM 
EDTA and 0.22 mM BHT. For each condition, after the 
TBARS were assayed, the LDL was isolated again from 
the incubation mixture by ultracentrifugation (as described 
above) and examined by negative staining electron mi- 
croscopy and analysed for lipid and protein composition. 
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To determine whether the process is dependent on 
copper concentration, additional experiments were carried 
out using various copper/AGE-Alb (or Alb) molar ratio 
(from 0 to 4) while maintaining constant the albumin/pro- 
tein LDL weight ratio at 1. 
2.4. Investigations 
Assay for lipid peroxides 
The degree of oxidative modification of LDL was deter- 
mined by measuring the thiobarbituric acid reactive sub- 
stances (TENRS), using a malondialdehyde (MDA) stan- 
dard curve; results were expressed as nmol MDA/mg 
protein LDL, as described in [26]. Alternatively the conju- 
gated dienes were determined spectrophotometrically ac- 
cording to the method described by Esterbauer 1271. 
Protein analysis 
Protein concentration was determined by a modified 
Lowry method [28] using bovine serum albumin as stan- 
dard. For gel electrophoresis, samples of each LDL frac- 
tion were precipitated with 7% trichloroacetic acid and 
0.015% sodium deoxycholate (final concentration), and 
heated at 100°C (for 3 min) in 0.06 M Tris-buffered (pH 
Fig. 1. Effect of AGE-Alb on the morphology of normal human serum LDL (nLDL) incubated in oxidative conditions. Negative staining electron 
microscopy showed that, as compared to LDL particles prior to the incubation (a), after exposure to 1 PM CuSO, for 24 h, at 37”C, the particles were 
slightly aggregated (arrow), some appearing as compact droplets (d) or as vesicles (arrowhead) (b). Native albumin added to the incubation medium 
prevents the changes in LDL morphology (b, inset). Addition of AGE-AI\, to the incubation medium induced substantial changes in LDL that appeared as 
rouleaux (r), fused compact droplets (d) and aggregates (arrow). Few monomeric LDL particles (m) are also present cc). a-c: Bar = 100 nm. 
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Fig. 2. Effect of AGE-Alb on LDL isolated from diabetic patients (dLDL) (protein ratio (w/w) LDL/AGE-Alb = 1). Negatively stained micrographs 
revealed that while the native probes consisted in monomers only (a), after 24 h incubation with 1 /JM C&O, at 37”C, dLDL appeared as compact 
droplets (d), vesicles (v) and monomers (m) (b). In the presence of AGE-Alb, drastic modifications and massive reorganization of the particles occur: 
dLDL appeared mostly as lipid droplets (d) and collapsed vesicles (v) (c and d) and sometimes as large aggregates (e). a-e: Bar = 100 nm. 
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6.8) containing 2% SDS and 5% P-mercaptoethanol. 
Aliquots (lo-25 pug) were applied on S-15% SDS-poly- 
acrylamide gradient gel [29] and electrophoresed at a 
constant current of 10 mA for 14 h. Gels were stained with 
0.1% Coomassie Brilliant Blue G-250 in 50% methanol 
and 10% acetic acid. 
Lipid analysis 
LDL cholesterol was measured chemically [30] or enzy- 
matically using a Sigma kit. Unesterified and esterified 
cholesterol were quantitated after solvent extraction [31] 
and subsequent separation by thin-layer chromatography 
(TLC). The latter was performed on precoated plates using 
petroleum ether-diethylether-acetic acid (9O:lO:l) as devel- 
oping system. Upon exposure to, and visualization with 
iodine vapours, the spots corresponding to the lipid stan- 
dards (run on the same plates) were scraped from the gel 
[32] and chemically measured [30]. Solvent blanks and 
blank areas from each TLC plate were measured and 
subtracted from the values of corresponding probes. Phos- 
pholipid classes were quantitated as in [33] after their 
separation by TLC according to Skipski [34]. Lipid phos- 
phorus was converted to phospholipid using a multiplica- 
tion factor of 25. Appropriate blanks and controls were 
included for each lipid class assay. 
Negative staining electron microscopy 
Samples of LDL obtained after incubation in each of 
the above conditions were placed on grids and stained with 
1% sodium phosphotungstate adjusted to pH 8.0 [35]. For 
each experimental condition, 3-5 grids of each sample 
were examined with a Philips 201C and a 400 HM elec- 
tron microscope. 
3. Results 
3.1. Characterization of probes 
Native LDL appeared on SDS-PAGE as a single protein 
band at the expected position of apo B. The level of 
glycation of nLDL (collected from 64 subjects) or dLDL 
(38 subjects) determined using hydroxymethyl furfural 
(HMF) as standard according to the method in 1201 had 
indicated values of 160 f 24 nmol HMF/mol apoB for 
nLDL and of 270 f 50 nmol HMF/mol apoB for dLDL. 
In the case of NIDDM patients, the level of LDL glycation 
was constantly higher than that of normal subjects (P < 
0.001 when compared with normal’subjects). 
3.2. AGE-Alb effect on LDL morphology 
Samples of nLDL and dLDL, freshly isolated or after 
incubation with AGE-Alb in different oxidative conditions, 
and isolated again (to remove AGE-Alb) were examined 
by negative staining electron microscopy. As expected, 
native nLDL appeared as monomeric particles ranging in 
size between 20 and 23 nm (Fig. la). Upon incubation for 
24-48 h at 37°C in either autoxidative conditions or with 1 
/.LM copper, nLDL appeared as monomers, as aggregated 
or fused particles (Fig. lb). When subjected to similar 
conditions but in the presence of AGE-Alb significant 
changes in LDL morphology occurred. In addition to rare 
monomers, nLDL often appeared as large aggregates, 
rouleaux and fused particles; these changes were particu- 
larly prominent in the case of Cu2+-induced oxidation 
(Fig. lc). In contrast to AGE-Alb, addition of Alb to the 
incubation mixture preserved the native appearance of 
LDL (Fig. 1, inset). 
When subjected to conditions similar to those described 
above, dLDL was even more drastically modified by AGE- 
Alb (Fig. 2). Isolated dLDL particles were not different 
from nLDL in negative staining (Fig. 2a). However, upon 
oxidation, besides monomers, vesicles and fused particles 
were present (Fig. 2b). These modifications were abolished 
by addition of native albumin to the incubation medium. 
By contrast, addition of AGE-Alb during incubation in- 
duced even more severe alteration in the dLDL morphol- 
ogy that appeared mainly as vesicles, collapsed and fused 
particles (Fig. 2c,d) and occasionally as large aggregates, 
consisting possibly of partially delipidated apo B deposits 
and excess surface lipids (Fig. 2e); only few monomeric 
particles were still present (Fig. 2c,d). 
3.3. AGE-Alb effect on the TBARS and conjugated dienes 
generation during nLDL or dLDL oxidation 
nLDL 
When freshly isolated nLDL was maintained for 24 h at 
37°C the level of lipid peroxides expressed as TBABS 
corresponded to a mild oxidation (N 10 nmol MDA/mg 
Table 1 
Effect of AGE-Alb on TBARS and conjugated dienes generation during 
oxidation of normal LDL (nLDL) 
Experimental conditions a TBARS Conjugated 
(nmol MDA/mg dienes AA 
protein LDL) (234 nm) b 
nLDL: freshly isolated 0.8f0.3 
nLDL: autoxidation, 24 h 10.2k3.1 0.81 f 0.03 
nLDL: autoxidation + AGE-Alb 4.0f 1.2 0.59 * 0.07 
nLDL: autoxidation + Alb 3.1 f 1.1 0.62 f 0.09 
nLDL+Cu’+ (24 h) 33.0 f 1.4 1.04*0.04 
nLDL+&+ +Alb 4.3*1.1 0.73 f 0.05 
nLDL + Cu2+ + AGE-Alb 6.1k1.4 0.79 f 0.05 
a LDL (0.1 mg/ml) was subjected to autoxidation at 37°C for 24 h in the 
absence or presence of AGE-Alb or Alb. The lipoprotein: albumin weight 
ratio was 1:l. Values represent the average of three experiments. 
TBARS, thiobarbituric acid reactive substances; MDA, malondialdehyde; 
Alb, bovine serum albumin; AGE-Alb, advanced glycosylated albumin. 
b Conjugated dienes are expressed as the increase in absorbance at 234 
nm of each probe. All probes had concentrations of 0.5 mg LDL 
protein/ml. 
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Table 2 
Effect of AGE-Alb on generation of TBARS and conjugated dienes 
during oxidation of diabetic LDL (dLDL) 
Experimental conditions a TBARS 
(nmol MDA/mg 
protein LDL) 
Conjugated 
dienes AA 
(234 nm) b 
dLDL: freshly isolated 
dLDL: autoxidation, 24 h 
dLDL: autoxidation + AGE-Alb 
dLDL: autoxidation + Alb 
dLDL+Cu’+ (24 h) 
dLDL + Cu*+ + Alb 
dLDL + Cu2+ + AGE-Alb 
1.8kO.4 
26.4 + 4.5 0.99*0.16 
8.4+ 1.4 0.73 + 0.09 
4.3 + 0.6 0.76 + 0.03 
36.1+ 1.7 1.44f0.10 
7.6t2.2 0.83 to.09 
9.5 t 3.5 0.95 f 0.06 
a The mixture containing dLDL (0.1 mg/ml) and without or in the 
presence AGE-Alb or Alb (0.1 mg/ml) was incubated with 1 PM 
CuSO,, for 24 h at 37°C. 
TBARS, thiobarbituric acid reactive substances; MDA, malondialdehyde; 
Alb, bovine serum albumin; AGE-Alb, advanced glycosylated albumin; 
dLDL, diabetic LDL. 
b Conjugated dienes are expressed as in Table 1. 
protein). The presence of Alb or AGE-Alb in the incuba- 
tion mixture, reduced by 60% and 70%, respectively, the 
TBARS level (Table 1). Peroxidation of nLDL in the 
presence of copper gave a value of w 33 nmol MDA/mg 
protein, indicating an extensive lipid peroxidation. The 
process was efficiently reduced by addition of Alb or 
AGE-Alb in the incubation medium (Table 1). 
aYL.DL 
When freshly isolated, dLDL had constantly a higher 
level of TBARS than nLDL (- 1.8 and N 0.8 nmol 
MDA/mg protein LDL, respectively). Subjected to the 
same conditions as above (autoxidation or Cu2+-induced 
04 0 0.5 1 1.5 2 ---Fir- 2.5 4 
copper/albumin molar ratio 
- nLDL -+- nLDL+AGE -+- nLDL+Alb 
Fig. 3. Dependence on copper concentration of LDL peroxidation in the 
presence of AGE-Alb or Alb, expressed as TBARS generation. The 
albumins were dialyzed for 24 h at 4°C against Tris-buffered saline (pH 
7.4), containing 0.1% EDTA (to remove possible impurification with 
copper), followed by extensive dialysis in Tris-buffered saline (pH 7.4) 
without EDTA. For all experiments, the albumin/protein LDL ratio was 
1:l (w/w), whereas the concentration of copper ions:albumin molar ratio 
was increased from 0 to 4. Note that AGE-Alb ceases to prevent LDL 
peroxidation at the molar ratio of 1, whereas albumin is effective up to 
the copper/albumin molar ratio of 2.5. 
CWlJC (relative ratio) 
LDL LDL+Alb LDL+AGE-Alb oxidized LDL 
- nLDL @#% dLDL 
LysoPC/PC (relative ratio) 
0.8 
0.6 
0.4 
0.2 
n 
LDL LDL+Alb LDL+A&E-Alboxidirbd LDL 
m nLDL m dLDL 
Fig. 4. Changes in the ratio between lipid classes of nLDL and dLDL 
incubated in oxidative conditions (1 PM copper sulfate) in the presence 
of AGE-Alb or Alb. (A) Variation in the CE/UC relative ratio deter- 
mined by thin layer chromatography and calorimetric assay. (B) Modifi- 
cation of relative ratio between phospholipid classes. CE = cholesteryl 
esters; UC = unesterified cholesterol; PC = phosphatidylcholine; LysoPC 
= lysophosphatidylcholine. Values represent the average of four experi- 
ments 
oxidation), the level of TBARS values detected for dLDL 
were always higher than those for nLDL. As in the case of 
nLDL, the generation of TBARS was significantly reduced 
when AGE-Alb or Alb were added to the incubation 
mixture (Table 2). 
In all experimental conditions described above, addition 
of oxidation inhibitors (1 mM EDTA and 0.22 PM BHT) 
maintained the TBARS value at the level of the native 
probes. Determination of conjugated dienes indicated simi- 
lar variations as for TBARS (Tables 1 and 2). 
These experiments and the emerging data indicated that 
at Alb/LDL protein weight ratio of l:l, AGE-Alb and 
especially Alb prevent the generation of TBARS in the 
absence or presence of Cu2+. To find out whether this 
effect was dependent on Cu2+ concentration, additional 
procedures were carried out using various Cu2+/albumin 
molar ratio (from 0 to 4) while maintaining a constant 1:l 
albumin/LDL protein weight ratio. These experiments 
showed that the antioxidant effect of native albumin was 
efficient up to a Cu2+/albumin molar ratio of 2.5. This 
threshold was significantly lower for AGE-Alb that inhib- 
ited the generation of lipid peroxidation up to the molar 
ratio of copper/AGE-Alb of 1:l (Fig. 3). As the molar 
ratio of copper ions to AGE-Alb went above 1, the TBARS 
attained gradually the same values as those of LDL oxi- 
dized for 24 h at 37°C (Fig. 3). This is possibly due to a 
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reduced capacity of AGE-Alb to bind Cu2+ ions, as 
already reported for glycated Alb [36]. 
3.4. AGE-Alb effect on LDL chemistry 
Analysis of major lipid classes of nLDL and dLDL 
incubated in oxidative conditions (1 pm C&O,) revealed 
that, both free cholesterol and lysophosphatidylcholine 
content were greatly augmented as compared with the 
respective native lipoproteins. Consequently, the choles- 
terol ester/unesterified cholesterol (CE/UC) ratio was 
decreased, whereas the lysophosphatidylcholine/phospha- 
tidylcholine (LysoPC/PC) ratio was increased (Fig. 4A 
and B). As expected, addition of native Alb to the incuba- 
tion medium preserved these lipid ratios at normal values 
for both nLDL and dLDL (Fig. 4). By contrast, analysis of 
lipid content of nLDL and dLDL oxidized in the presence 
of AGE&b showed important alterations comparable to 
but different from those detected in oxidized lipoproteins 
in the absence of AGE-Alb. As compared to normal LDL, 
the CE/UC ratio decreased N 1.3-fold for nLDL and 
N 3-fold for dLDL. The LysoPC/PC ratio increased N 3- 
CE/UC ratio 
6 (1----- 
nLDL 
A 
nLDL+AGE-Alb 
m nLDLfreshly isolated ~ nLDL,4’C 
a nLDL,37’C nLDL,37% 
+inhibitors 
CENC ratio 
dLDL dLDL+AGE-Alb 
m dLDLfreshly isolated @8 dLDL, 4% 
n dLDL, 370c dLDL, 37% 
+inhibitors 
Fig. 5. CE/UC ratio of nLDL (A) and dLDL (B) incubated for 48 h in 
the absence or presence of AGE-Alb, in the following conditions: at 4”C, 
at 37°C and at 37°C in the presence of oxidation inhibitors (EDTA and 
BHT). Note that the presence of inhibitors does not prevent the AGE-Aib 
to affect the lipid composition of nLDL and especially dLDL. CE = 
cholesteryl esters; UC = unesterified cholesterol. The results are from one 
representative experiment. 
LysoPWPC ratio 
0.4 fl - 
nLDL nLDL+AGE-Alb 
m nLDLfreshly isolated k%8# nLDL, 4’C 
0 nLDL, 37% nLDL. 37% 
+inhibitors 
LysoPWPC ratio 
::: flppF B 
0.7 
0.6 
0.5 
0.4 
0.3 _- 
dLDL dLDL+AGE-Alb 
m dLDLfreshly isolated &%8 dLDL, 4’C 
/ dLDL, 370c dLDL, 37’C 
+inhibitors 
Fig. 6. LysoPC/PC ratio of nLDL (A) and dLDL (B) incubated in 
various conditions (4”C, 37”C, 37°C with oxidation inhibitors EDTA and 
BHT) for 48h, with or without AGE-Alb. The weight ratio AGE- 
Alb/LDL = 1:l. Note the slight increase ( _ 1.5-fold) in the relative 
phospholipid ratio of dLDL exposed to AGE-Alb, even in the presence of 
oxidation inhibitors. LysoPC = lysophosphatidylcholine; PC = phospha- 
tidylcholine. Results are from one representative experiment. 
fold for nLDL and N 3.5-fold for dLDL (Fig. 4B). In all 
experiments these changes were more prominent in the 
case of dLDL. Similar results were obtained in experi- 
ments in which gAlb was removed from AGE-Alb prepa- 
ration (by GlycoGel B chromatography) this suggested 
that, if present, gAlb had no influence on AGE-Alb-in- 
duced modifications of lipoprotein. 
Taken together, these results showed that in oxidative 
conditions, AGE-Alb induced modifications in the lipid 
content of nLDL and dLDL which are not accompanied by 
a significant increase in TBARS level (Tables 1 and 2). 
These surprising findings led us to address the issue 
whether AGE-Alb by itself may induce physico-chemical 
alterations of LDL particles, irrespective of the presence of 
oxidative conditions. To this purpose, we incubated either 
nLDL or dLDL with AGE-Alb at 37°C in the absence or 
presence of oxidation inhibitors (EDTA and BHT) or at 
4°C. As previously mentioned, in the latter two conditions 
the TBARS values were similar to those of the native 
particles. Incubation of nLDL for 48 h either at 4°C or at 
37°C in the presence of inhibitors, had no effect on 
CE/UC ratio. As expected, incubation at 37°C in the 
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absence of inhibitors (autoxidation) decreased by u 33% 
the CE/UC ratio (Fig. 5A). This is probable due to a mild 
oxidation of the lipoproteins, a result that is in good 
agreement with the increase in TBMS values detected in 
such conditions. Addition of AGE-Alb to nLDL samples in 
the three conditions tested (37°C 37°C with inhibitors and 
at 4”C), showed that at 4°C there is no significant change 
in CE/UC ratio, as compared with nLDL, however, at 
37°C a characteristic decrease of N 24% and m 37% was 
detected in the presence or absence of inhibitors, respec- 
tively (Fig. 5A). The situation was somehow similar for 
dLDL, but the CE/UC ratio was even lower (N 40%) 
when AGE-Alb was added at 37°C in the presence of 
oxidation inhibitors (Fig. 5B). 
Determination of LysoPC/PC ratio indicated that in the 
absence of AGE-Alb no change occurred at 4°C and 37°C 
kDa 
205 
116- 
78- 
45- 
A a b c d 
kDa 
205- 
116- 
78- 
8 a b c d 
Fig. 7. SDS-PAGE of LDL obtained from normal (nLDL) or diabetic 
subjects (dLDL) oxidized in the presence of AGE-Alb or albumin (Alb) 
and further isolated by ultracentrifugation (to remove Alb or AGE&b). 
(A) Freshly isolated nLDL (a) oxidized for 24 h (b), in the presence of 
albumin (c) or AGE-Alb (d). (B) dLDL, before oxidation (a), after 24 h 
oxidation (b), in the presence of Alb 6-z) or of AGE-Alb Cd). The latter 
significantly affects the apo B especially of dLDL. 
in the presence of EDTA and BHT; however, in the 
absence of inhibitors at 37°C a N 2-fold increase and a 
N 3-fold increase of this ratio was obtained for nLDL and 
dLDL, respectively (Fig. 6A, B). When AGE-Alb was 
added to nLDL, the LysoPC/PC ratio was not signifi- 
cantly modified (Fig. 6A). In the absence of inhibitors, the 
effect of AGE-Alb on dLDL was not different than that 
observed when dLDL was incubated without AGE-Alb. 
However, a slight (1.5-fold) increase in the LysoPC/PC 
ratio was recorded in the presence of inhibitors. 
Since AGE-Alb induced significant alterations in the 
lipid composition of lipoproteins even in the presence of 
inhibitors of oxidation, we can assume that AGE-Alb by 
itself was responsible for these modifications. It was obvi- 
ous that in all cases, dLDL was more susceptible and 
reactive than nLDL, probably because minimal, unde- 
tectable intrinsic modifications are present in dLDL 
molecule. 
Protein analysis by SDS-PAGE revealed that apo B-100 
was the only protein present in nLDL whereas some fine 
lower molecular weight protein bands were present in 
freshly isolated dLDL (Fig. 7a,b). When subjected to 
copper-induced oxidation, the electrophoretic pattern of 
both nLDL and dLDL showed drastically fragmented apo 
B; addition of native Alb prevented in part the degradation 
of apo B especially in the case of nLDL suggesting a mild 
breakdown of the protein. The degradative process was 
more pronounced for dLDL (Fig. 7a,b). In contradistinc- 
tion, the incubation of the probes in the presence of 
AGE&b had a severe effect on the protein. On SDS-PAGE 
nLDL exhibit numerous lower molecular weight peptide 
fragments ranging between 120 and 250 kDa. In the case 
of dLDL, the degradation of apo B was more prominent 
and only few protein bands of an apparent molecular mass 
of 66 and 58 kDa were present (Fig. 7b). 
4. Discussion 
The experiments reported here, demonstrate that: (a) 
AGE-Alb directly induces structural and chemical modifi- 
cations of human nLDL and dLDL; (b) these modifications 
are enhanced in oxidative conditions without significant 
changes in the TBARS level; (c) in all experimental 
conditions dLDL is more susceptible to the AGE-Alb-in- 
duced changes. 
We choose to study the interaction between AGE-Alb 
and LDL in an in vitro system, so as to avoid any 
interference of other cellular or extracellular components. 
Initially, we tested whether AGE-Alb still has the antioxi- 
dant potential on LDL peroxidation as already reported for 
albumin [ 151. The results indicated that, in terms of TBAES 
generation, the situation is to a certain extent similar to 
that of Alb, in both cases the levels detected being low. 
However, there is a clear difference with respect to the 
threshold of Cu’+/albumin ratio, which for AGE-Alb is 
34 A. Dobrian, M. Simionescu/Biochimica et Biophysics Acta 1270 (1995) 26-35 
2.5-times lower than for Alb. This finding corroborates 
well with published data indicating that glycated albumin 
has a diminished binding capacity for copper ions [5,36]. 
Interestingly, short term (14 days) reversibly glycated al- 
bumin @lb), upon incubation with nLDL and dLDL in 
the conditions described for AGE-Alb, generates a signifi- 
cant amount of TBARS, without notable change in the 
lipid composition of lipoproteins (unpublished observa- 
tions). These data suggest possible different mechanisms 
of action of gAlb and AGE-Alb on LDL molecule. 
It was intriguing that in the absence of significant 
oxidative modifications, at least in terms of generation of 
TBARS (or conjugated dienes), the morphology of LDL 
particles was drastically changed, the lipid composition 
modified and the apo B integrity altered. Thus, upon 
exposure to AGE-Alb, in oxidative conditions, nLDL and 
especially dLDL appear aggregated, vesiculated, or as 
collapsed fused particles. These modifications are accom- 
panied by a significant increase in unesterified cholesterol 
(UC) and lysophosphatidyl choline (LysoPC) and a drastic 
degradation of apo B. The strong effect of AGE-Alb on 
dLDL, in particular in oxidative conditions (Fig. 4A), may 
be due to the lipoprotein higher concentration in TBARS, 
and to the increased glycation of apo B (as compared to 
normal LDL) that intensify dLDL susceptibility to these 
aggressive factors. These changes could be due either to (i) 
interference of AGE&b in TBARS determination (the 
detailed chemistry of AGE products is rather unknown) 
and in fact, oxidation still occur, or (ii) that the modifica- 
tions observed are due to the direct effect of the AGE-Alb 
on LDL particles without generation of augmented amounts 
of TBARS. To eliminate the potential influence of oxida- 
tion, we designed a series of experiments in which copper 
ions were omitted and nLDL or dLDL were incubated with 
AGE-Alb either at 37°C in the presence of oxidation 
inhibitors, or at 4°C. These experiments showed that AGE- 
Alb, even in the presence of EDTA and BHT, produced 
morphological and chemical alterations of LDL molecule. 
Consequently, it is safe to conclude that AGE-Alb by itself 
alters the normal or diabetic LDL, and the oxidative 
conditions enhance these modifications. 
There were no changes in lipoprotein structure when 
experiments were performed at 4°C. These suggest the 
possible involvement of an enzymatic-like process which 
occur at 37°C only; it was reported that in certain condi- 
tions apo B exhibits a phospholipase A2-like activity [37]. 
The pattern of protein fragmentation, constantly observed 
in AGE-Alb-exposed LDL, could be, at least in part, the 
result of a phospholipase-like activity of apo B. It was also 
demonstrated that, in certain conditions, albumin exerts an 
esterase-like activity [38]. We consider the possibility that 
conformational changes induced by advanced glycosyla- 
tion in the Alb molecule could intensify albumin’s es- 
terase-like activity, and consequently could explain a raise 
in the UC content of LDL. This possibility was tested by 
incubating Alb or AGE-Alb with reconstituted 
[‘4C]cholesteryl oleate LDL and assessing the 14C-free 
fatty acids released [39]; no differences between Alb and 
AGE-Alb were detected. 
In general, the AGE-Alb induced similar modifications 
of LDL either in the absence or in the presence of oxida- 
tive conditions, but the latter enhances clearly these alter- 
ations. Furthermore, in all experiments, the structural and 
chemical changes were stronger for dLDL suggesting that 
the molecule is more labile and predisposed to further 
alterations. It has been reported that LDL from NIDDM 
patients is significantly more glycosylated as compared to 
that of normal subjects [40] and that in elderly subjects 
hyperinsulinemia could be correlated with the presence in 
plasma of a more consistent fraction of small, dense, 
atherogenic LDL [41]. Nevertheless, as indicated by Lyons 
et al., in diabetic patients the increase in the glycative 
stress is not always associated with an inherent increase in 
the oxidative stress [40]. Still, accelerated atherosclerosis is 
frequently associated with diabetes. Our results support 
these data, and suggest that extended glycation, rather than 
oxidation of lipoproteins, at least at the onset of the 
process, makes LDL prone to AGE-Alb induced major 
modifications. 
It has been shown that both LDL and AGE-Alb transcy- 
tose the endothelial layer [42,43]. One can assume that 
within the arterial wall of diabetic subjects the transcy- 
tosed dLDL and AGE-Alb may interact and rapidly gener- 
ate modified forms of lipoproteins similar to those we have 
detected as the result of their in vitro interaction. Similar 
forms of modified and reassembled lipoproteins were ob- 
served in the arterial intima of hypercholesterolemic ani- 
mals [44,45] and are believed to be highly atherogenic, 
inducing the foam cell formation. We assume that the 
rapid and drastic changes of glycated lipoproteins that 
occur in the presence of AGE-Alb could result in the 
formation of modified lipoproteins in the arterial wall of 
diabetic subjects (in the absence of hypercholesterolemic 
diet or strong prooxidant conditions), which could be one 
of the events that trigger accelerated atherosclerosis, the 
most common complication of diabetes. 
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